Pfizer (PFIZER) | Stock Overview & Key Data
Pfizer Performance Comparison
Stock Range
Today's Range
Low: ₹5,162.00
High: ₹5,252.00
on October 3, 2025
52 Week Range
Low: ₹3,701.00
High: ₹6,020.00
on April 7, 2025
on October 15, 2024
All-Time High: ₹6,451.15 on September 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR240.2B
EPS
176.52
P/E Ratio (TTM)
29.59
Forward P/E
31.20
P/B Ratio
5.66
PEG Ratio
1.09
Div. Yield
1.27%
ROE
18.20%
Beta
0.113
Debt to Equity
2.57
Financial Highlights
Profitability
Gross Margin
64.97%
Operating Margin
32.44%
Profit Margin
34.83%
Returns and Earnings
Return on Assets (TTM)
15.63%
Return on Equity (TTM)
18.20%
EBITDA
INR9.7B
Net Income (TTM)
INR8.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR507.47
Quarterly Revenue Growth (YoY)
7.10%
Quarterly Earnings Growth (YoY)
27.20%
Dividend Information
Last 12-Month Dividend
₹70.00
Current Dividend Yield
1.27%
3-Year Average Dividend Yield
0.58%
3-Year Average Annual Dividend
₹46.67
3-Year Total Dividends
₹140.00
Ex-Dividend Date
July 9, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Pfizer PFIZER | 240.16B Large-cap | 5.91% | 0.94% | -9.69% | 28.32% | -1.60% | -7.01% | 17.65% | 3.99% |
| GlaxoSmithKline GLAXO | 466.84B Large-cap | 2.57% | -1.29% | -16.99% | -4.05% | 22.80% | 0.26% | 96.82% | 83.37% |
| Sanofi India Limited SANOFI | 108.48B Mid-cap | -0.82% | -8.19% | -22.76% | -21.55% | -22.63% | -31.42% | -20.44% | -45.42% |
| Sanofi Consumer SANOFICONR | 110.67B Mid-cap | -2.89% | -6.32% | -7.53% | -0.12% | -2.26% | -3.81% | -2.16% | -2.16% |
| Marksans Pharma MARKSANS | 77.77B Mid-cap | 1.31% | -3.75% | -35.83% | -28.57% | -45.34% | -42.54% | 252.44% | 210.98% |
| Senores SENORES | 32.95B Small-cap | -4.06% | -1.93% | 18.10% | 22.01% | 20.44% | 20.06% | 20.06% | 20.06% |
Ownership & Short Interest
Insider Ownership
66.02%
Institutional Ownership
14.88%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
51K
Average 90-Day Volume
30K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PFIZER's 52-week high and low?
- In the last 52 weeks, Pfizer reached a high of ₹6,020.00 (on October 15, 2024) and a low of ₹3,701.00 (on April 7, 2025).
- What is the market cap and P/E ratio for PFIZER?
- Curious about Pfizer's size and valuation? Its market capitalization stands at 240.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is 29.59, and the forward P/E (looking ahead) is 31.20.
- Does PFIZER pay dividends? If so, what's the yield?
- Yes, Pfizer is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.27%, and the company has paid an average of ₹46.67 per share annually over the past 3 years.
- Who are Pfizer's main competitors or similar companies to consider before investing?
When looking at Pfizer, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO466.84B Healthcare Drug Manufacturers - General 0.26% 96.82% Sanofi India Limited
SANOFI108.48B Healthcare Drug Manufacturers - General -31.42% -20.44% Sanofi Consumer
SANOFICONR110.67B Healthcare Drug Manufacturers - General -3.81% -2.16% Marksans Pharma
MARKSANS77.77B Healthcare Drug Manufacturers - General -42.54% 252.44% Senores
SENORES32.95B Healthcare Drug Manufacturers - General 20.06% 20.06% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pfizer Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Pfizer's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.20%, the Debt to Equity ratio from the most recent quarter is 2.57, and its Gross Profit Margin stands at 64.97%.
- What is the recent revenue and earnings growth for PFIZER?
- Looking at Pfizer's growth, its revenue over the trailing twelve months (TTM) was INR23B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.10%, and quarterly earnings saw a YoY growth of 27.20%.
- How much of PFIZER stock is held by insiders and institutions?
- Wondering who owns Pfizer stock? Company insiders (like executives and directors) hold about 66.02% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.